AN2 Therapeutics, Inc. SEC filings ANTX
AN2 Therapeutics, Inc. has 384 filings in SEC EDGAR's recent list, going back to Sep 24, 2021. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 20, 2026 | — |
| CORRESP | Letter to the SEC | Apr 16, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2026 | — |
| D | Filing | Mar 25, 2026 | — |
| 8-A12B | Filing | Aug 19, 2024 | — |
| EFFECT | Filing | Apr 13, 2023 | — |
| CORRESP | Letter to the SEC | Apr 11, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2023 | — |
| SEC STAFF LETTER | Filing | Mar 24, 2022 | — |
| EFFECT | Filing | Mar 24, 2022 | — |
| CERT | Filing | Mar 24, 2022 | — |
| 8-A12B | Filing | Mar 22, 2022 | — |
| CORRESP | Letter to the SEC | Mar 22, 2022 | — |
| CORRESP | Letter to the SEC | Mar 22, 2022 | — |
| SEC STAFF LETTER | Filing | Mar 10, 2022 | — |
| DRSLTR | Filing | Jan 19, 2022 | — |
| DRS/A | Filing | Jan 19, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2021 | — |
| DRS/A | Filing | Nov 19, 2021 | — |
| DRSLTR | Filing | Nov 18, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 22, 2021 | — |
| DRS | Filing | Sep 24, 2021 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ANTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1880438
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.